hello world
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
Stocks in play: Microbix Biosystems Inc.
Announces that it has upgraded its European Union regulatory compliance for its diagnostic assay quality assessment products. Specifically, Microbix has obtained recognition of its quality management system compliance with the EU In Vitro Diagnostics Regulation and Conformité Européenne Certification for an initial portfolio of 11 REDx™ QAPs – two essential regulatory achievements in order for Microbix to have complete access to EU-regulated markets and fully serve its customers. Microbix Biosystems Inc. shares T.MBX are trading up $0.01 at $0.36.
